2024 Q2 Form 10-Q Financial Statement

#000143774924015111 Filed on May 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $7.042M $4.957M
YoY Change 28.95% -31.97%
Cost Of Revenue $4.090M $2.928M
YoY Change 18.04% -34.67%
Gross Profit $2.952M $2.029M
YoY Change 47.9% -27.66%
Gross Profit Margin 41.92% 40.93%
Selling, General & Admin $3.245M $3.345M
YoY Change 11.32% 3.08%
% of Gross Profit 109.93% 164.86%
Research & Development $422.0K $376.0K
YoY Change 2.18% 72.48%
% of Gross Profit 14.3% 18.53%
Depreciation & Amortization $96.00K $80.00K
YoY Change 2.13% 1.27%
% of Gross Profit 3.25% 3.94%
Operating Expenses $3.667M $3.721M
YoY Change 10.19% 7.45%
Operating Profit -$715.0K -$1.692M
YoY Change -46.32% 157.14%
Interest Expense $0.00 $0.00
YoY Change -100.0% -100.0%
% of Operating Profit
Other Income/Expense, Net -$34.00K $1.673M
YoY Change 142.86% -1958.89%
Pretax Income -$415.0K $292.0K
YoY Change -60.25% -170.53%
Income Tax $6.000K $11.00K
% Of Pretax Income 3.77%
Net Earnings -$421.0K $281.0K
YoY Change -59.67% -167.87%
Net Earnings / Revenue -5.98% 5.67%
Basic Earnings Per Share -$0.01 $0.01
Diluted Earnings Per Share -$0.01 $0.01
COMMON SHARES
Basic Shares Outstanding 30.39M 30.39M
Diluted Shares Outstanding 30.48M 30.76M

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $20.07M $23.25M
YoY Change -28.28% -13.12%
Cash & Equivalents $10.40M $11.38M
Short-Term Investments $9.669M $11.87M
Other Short-Term Assets $1.117M $1.295M
YoY Change -13.21% -4.07%
Inventory $462.0K $537.0K
Prepaid Expenses
Receivables $8.651M $7.104M
Other Receivables $0.00 $0.00
Total Short-Term Assets $30.30M $32.19M
YoY Change -17.17% -9.01%
LONG-TERM ASSETS
Property, Plant & Equipment $4.571M $4.572M
YoY Change 4.65% 4.62%
Goodwill $2.116M $2.116M
YoY Change 0.0% 0.0%
Intangibles $337.0K $343.0K
YoY Change -11.78% -14.46%
Long-Term Investments $10.36M $8.879M
YoY Change 112.56% 25.87%
Other Assets $756.0K $764.0K
YoY Change -4.18% -4.02%
Total Long-Term Assets $18.69M $17.26M
YoY Change 43.51% 15.79%
TOTAL ASSETS
Total Short-Term Assets $30.30M $32.19M
Total Long-Term Assets $18.69M $17.26M
Total Assets $48.99M $49.45M
YoY Change -1.24% -1.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.938M $1.852M
YoY Change -5.13% -49.27%
Accrued Expenses $1.190M $1.817M
YoY Change 9.07% 65.63%
Deferred Revenue $276.0K $761.0K
YoY Change -70.58% 78.22%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.482M $4.530M
YoY Change -12.56% -12.46%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $276.0K $276.0K
YoY Change -1.43% -0.36%
Total Long-Term Liabilities $276.0K $276.0K
YoY Change -1.43% -0.36%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.482M $4.530M
Total Long-Term Liabilities $276.0K $276.0K
Total Liabilities $5.425M $5.490M
YoY Change -8.96% -3.35%
SHAREHOLDERS EQUITY
Retained Earnings -$117.7M -$117.2M
YoY Change 0.19% 0.72%
Common Stock $165.4M $165.3M
YoY Change 0.26% 0.27%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $43.57M $43.96M
YoY Change
Total Liabilities & Shareholders Equity $48.99M $49.45M
YoY Change -1.24% -1.66%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$421.0K $281.0K
YoY Change -59.67% -167.87%
Depreciation, Depletion And Amortization $96.00K $80.00K
YoY Change 2.13% 1.27%
Cash From Operating Activities -$1.589M -$1.075M
YoY Change 60.02% -206.44%
INVESTING ACTIVITIES
Capital Expenditures $90.00K $114.0K
YoY Change 23.29% 280.0%
Acquisitions
YoY Change
Other Investing Activities $784.0K -$4.891M
YoY Change 56.8% -43.68%
Cash From Investing Activities $694.0K -$5.005M
YoY Change 62.53% -42.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -95.00K $0.00
YoY Change -326.19%
NET CHANGE
Cash From Operating Activities -1.589M -$1.075M
Cash From Investing Activities 694.0K -$5.005M
Cash From Financing Activities -95.00K $0.00
Net Change In Cash -990.0K -$6.196M
YoY Change 88.93% -18.79%
FREE CASH FLOW
Cash From Operating Activities -$1.589M -$1.075M
Capital Expenditures $90.00K $114.0K
Free Cash Flow -$1.679M -$1.189M
YoY Change 57.5% -221.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
111000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
111000 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
18763000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
18703000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
483000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
468000 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31361303
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31361303
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30385297
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30825297
CY2023Q4 ftek Contract With Customer Contracts In Progress Number Of Contracts Identified As Loss Contracts
ContractWithCustomerContractsInProgressNumberOfContractsIdentifiedAsLossContracts
0 pure
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
976006
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
2251000 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 pure
CY2023Q1 us-gaap Standard Product Warranty Accrual Period Increase Decrease
StandardProductWarrantyAccrualPeriodIncreaseDecrease
0 usd
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
159000 usd
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-33059
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-5657551
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
27601 Bella Vista Parkway
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Warrenville
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60555-1617
CY2024Q1 dei City Area Code
CityAreaCode
630
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
845-4500
CY2024Q1 dei Security12b Title
Security12bTitle
Common Stock
CY2024Q1 dei Trading Symbol
TradingSymbol
FTEK
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
30385297
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11382000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17578000 usd
CY2024Q1 us-gaap Short Term Investments
ShortTermInvestments
11872000 usd
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
12136000 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7104000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6729000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
537000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
439000 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1295000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1439000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
32190000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
38321000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4572000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4539000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
2116000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
2116000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
343000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
358000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
582000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
609000 usd
CY2024Q1 us-gaap Long Term Investments
LongTermInvestments
8879000 usd
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
3664000 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
764000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
781000 usd
CY2024Q1 us-gaap Assets
Assets
49446000 usd
CY2023Q4 us-gaap Assets
Assets
50388000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1852000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2421000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
105000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
81000 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1289000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1252000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1284000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1934000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4530000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5688000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
512000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
533000 usd
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
172000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
172000 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
276000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
281000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
5490000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
6674000 usd
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
313000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
313000 usd
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
164957000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
164853000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-117248000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-117529000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1891000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1748000 usd
CY2024Q1 us-gaap Convertible Debt
ConvertibleDebt
76000 usd
CY2023Q4 us-gaap Convertible Debt
ConvertibleDebt
76000 usd
CY2024Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
2251000 usd
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
2251000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
43956000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
43714000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
49446000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
50388000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4957000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7287000 usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
2928000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
4482000 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3345000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3245000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
376000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
218000 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
6649000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
7945000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1692000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-658000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
-0 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
5000 usd
CY2024Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
311000 usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
339000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1673000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-90000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
292000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-414000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
281000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-414000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30385000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30296000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30756000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30296000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
281000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-414000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-143000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
86000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
138000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-328000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
44841000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-414000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
86000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
89000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
44602000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
43714000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
281000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-143000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
104000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
43956000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
281000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-414000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
80000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
79000 usd
CY2024Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
16000 usd
CY2023Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
11000 usd
CY2024Q1 us-gaap Interest And Dividend Income Securities Held To Maturity
InterestAndDividendIncomeSecuritiesHeldToMaturity
9000 usd
CY2023Q1 us-gaap Interest And Dividend Income Securities Held To Maturity
InterestAndDividendIncomeSecuritiesHeldToMaturity
95000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
104000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
89000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1250000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-990000 usd
CY2024Q1 ftek Increase Decrease Employee Retention Credit Receivable
IncreaseDecreaseEmployeeRetentionCreditReceivable
1677000 usd
CY2023Q1 ftek Increase Decrease Employee Retention Credit Receivable
IncreaseDecreaseEmployeeRetentionCreditReceivable
-0 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
99000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
116000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-151000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-51000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-563000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
934000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-609000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-519000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1075000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1010000 usd
CY2024Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
114000 usd
CY2023Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
30000 usd
CY2024Q1 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
7641000 usd
CY2023Q1 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
9685000 usd
CY2024Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
2750000 usd
CY2023Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
1000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5005000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8715000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-116000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
75000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6196000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7630000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
17578000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
23328000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11382000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15698000 usd
CY2024Q1 ftek Employee Retention Credit Receivable
EmployeeRetentionCreditReceivable
1677000 usd
CY2022Q4 ftek Investment Plan Maximum Amount Approved
InvestmentPlanMaximumAmountApproved
20000000 usd
CY2024Q1 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
20751000 usd
CY2023Q4 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
15800000 usd
CY2024Q1 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
6000 usd
CY2023Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
0 usd
CY2024Q1 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
92000 usd
CY2023Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
86000 usd
CY2024Q1 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
20665000 usd
CY2023Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
15714000 usd
CY2024Q1 us-gaap Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
11872000 usd
CY2024Q1 us-gaap Held To Maturity Securities Debt Maturities Within One Year Fair Value
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
11824000 usd
CY2024Q1 ftek Debt Securities Heldtomaturity Amortized Cost After Allowance For Credit Loss Maturity Allocated And Single Maturity Date After Year One Through Two
DebtSecuritiesHeldtomaturityAmortizedCostAfterAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo
8879000 usd
CY2024Q1 ftek Debt Securities Heldtomaturity Fair Value Maturity Allocated And Single Maturity Date After Year One Through Two
DebtSecuritiesHeldtomaturityFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo
8841000 usd
CY2024Q1 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
20751000 usd
CY2024Q1 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
20665000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
110000 usd
CY2023 ftek Provision For Doubtful Accounts Including Foreign Impact Of Foreign Exchange
ProvisionForDoubtfulAccountsIncludingForeignImpactOfForeignExchange
24000 usd
CY2023 ftek Allowance For Doubtful Accounts Receivable Chargeoffs Recoveries
AllowanceForDoubtfulAccountsReceivableChargeoffsRecoveries
23000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
111000 usd
CY2024Q1 ftek Provision For Doubtful Accounts Including Foreign Impact Of Foreign Exchange
ProvisionForDoubtfulAccountsIncludingForeignImpactOfForeignExchange
0 usd
CY2024Q1 ftek Allowance For Doubtful Accounts Receivable Chargeoffs Recoveries
AllowanceForDoubtfulAccountsReceivableChargeoffsRecoveries
-0 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
111000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4957000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7287000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4957000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7287000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4957000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7287000 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
761000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1279000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
372000 usd
CY2024Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1121000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
359000 usd
CY2024Q1 ftek Contract With Customer Contracts In Progress Number Of Contracts Identified As Loss Contracts
ContractWithCustomerContractsInProgressNumberOfContractsIdentifiedAsLossContracts
0 pure
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
6181000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
6019000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2024Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
3769000 usd
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
4300000 usd
CY2024Q1 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
1507000 usd
CY2023Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
2285000 usd
CY2024Q1 ftek Employee Retention Credit Receivable
EmployeeRetentionCreditReceivable
1677000 usd
CY2023Q4 ftek Employee Retention Credit Receivable
EmployeeRetentionCreditReceivable
0 usd
CY2024Q1 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
262000 usd
CY2023Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
255000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
111000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
111000 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7104000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6729000 usd
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
976006
CY2024Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
2251000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30385000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30296000
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
371000
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30756000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30296000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
270500
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.09
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
-0
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
-0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
270500
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.09
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y3M21D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
11000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
270500
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.09
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y3M21D
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
11000 usd
CY2024Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2850000
CY2022Q2 ftek Percentage Of Face Amount Of Letters Of Credit As Collateral
PercentageOfFaceAmountOfLettersOfCreditAsCollateral
1.50 pure
CY2022Q2 ftek Payment Basis Points On Face Value Of Letters Of Credit
PaymentBasisPointsOnFaceValueOfLettersOfCredit
0.0250 pure
CY2024Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
888000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4957000 usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
2928000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
2029000 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3345000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
376000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1692000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7287000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
4482000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
2805000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3245000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
218000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-658000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4957000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7287000 usd
CY2024Q1 us-gaap Noncurrent Assets
NoncurrentAssets
49446000 usd
CY2023Q4 us-gaap Noncurrent Assets
NoncurrentAssets
50388000 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
761000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1279000 usd
CY2024Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
159000 usd
CY2023Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
159000 usd
CY2024Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
100000 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
103000 usd
CY2024Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
0 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
101000 usd
CY2024Q1 ftek Other Accrued Liabilities Miscellaneous Current
OtherAccruedLiabilitiesMiscellaneousCurrent
264000 usd
CY2023Q4 ftek Other Accrued Liabilities Miscellaneous Current
OtherAccruedLiabilitiesMiscellaneousCurrent
292000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1284000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1934000 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual Period Increase Decrease
StandardProductWarrantyAccrualPeriodIncreaseDecrease
0 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
159000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.038 pure
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2024Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2024Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
ftek-20240331_def.xml Edgar Link unprocessable
0001437749-24-015111-index-headers.html Edgar Link pending
0001437749-24-015111-index.html Edgar Link pending
0001437749-24-015111.txt Edgar Link pending
0001437749-24-015111-xbrl.zip Edgar Link pending
ex_616567.htm Edgar Link pending
ex_616568.htm Edgar Link pending
ex_616569.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ftek-20240331.xsd Edgar Link pending
ftek20240331_10q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
ftek-20240331_cal.xml Edgar Link unprocessable
ftek-20240331_lab.xml Edgar Link unprocessable
ftek-20240331_pre.xml Edgar Link unprocessable
ftek20240331_10q_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending